Report ID: SQMIG35A3846
Report ID: SQMIG35A3846
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3846 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
145
|Figures:
78
Global Ivd Labware Market size was valued at USD 3.6 Billion in 2024 and is poised to grow from USD 3.82 Billion in 2025 to USD 6.08 Billion by 2033, growing at a CAGR of 6.0% during the forecast period (2026-2033).
The IVD labware market growth is driven by the increasing need for reliable and high-throughput diagnostic testing, thus prompting laboratories to shift away from manual use of glasses toward standardized disposable consumables. In vitro diagnostics (IVD) labware comprises of such items as sample collection devices, tubes, microplates, pipette tips, and assay cartridges. The quality of IVD labware directly impacts the analytical accuracy and analytical efficiency of the results obtained by these devices. The history of the IVD labware market has been influenced by the evolution of molecular and immunoassays; the regulatory emphasis on contamination control; and the occurrence of sporadic events, like the COVID-19 pandemic, which drove drastic increases in consumption of PCR plates and swabs. This combination of factors has led suppliers to develop more scalable, validated production processes and enhance their traceability standards, reinforcing labware's role in enabling healthcare.
The continuing innovations in molecular diagnostics and laboratory automation also play a significant role in the demand for IVD labware globally. Increased automation of clinical laboratories to support high-throughput PCR, NGS, and point-of-care molecular testing will create a need for validated, contamination-resistant consumables including plates and cartridges. Supplier's manufacturing scale advantages will increase as hospital networks adopt automated PCR polymerase chain reactions performed during surge testing while reducing the number of errors associated with the manual use of consumables. Consequently manufacturers investing in scalable production, quality systems and co-development with platform providers can convert technological adoption into revenue and margin expansion and broader system resilience.
How is AI Improving Efficiency in the IVD Labware Market?
The introduction of AI into the IVD labware industry is driving efficiency by automating repetitive tasks and improving overall data quality. A few important areas where AI is making an impact include the use of machine learning to optimize laboratory protocols, the use of automated image based quality control in the laboratory, the use of predictive maintenance for pipetting and dispensing systems, and the use of more intelligent ways to track samples and inventory. Currently, laboratories and suppliers are placing AI at the center of laboratory informatics and instrument control in order to eliminate manual error through rework and expedite laboratory workflow. Some of the main reasons for increasing the use of AI include increased demand for diagnostics and the increasing pressure to scale up from current levels of reproducibility to higher levels of reproducibility.
Several examples include liquid handling driven by artificial intelligence, adaptive scheduling, and automated plate inspections that will increase laboratory throughput and reliability when combined together. Most recently at the end of February 2025 Tecan announced the launch of the Veya: the 4th generation liquid handling platform of Tecan that has integrated AI automation and real-time data insights to reduce the hands-on time needed to prepare samples and increase the rate at which samples can be processed in a laboratory. This introduction highlights that by using AI at the instrument level it has the potential to increase reproducibility and further the adoption of IVD workflows on an efficient basis.
Market snapshot - (2026-2033)
Global Market Size
USD 3.6 Billion
Largest Segment
Plastic Labware
Fastest Growth
Plastic Labware
Growth Rate
6.0% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global IVD labware market is segmented by product, type, application, material, end user and region. Based on product, the market is segmented into Plastic Labware, Glass Labware and Others. Based on type, the market is segmented into Single-Use Labware and Reusable Labware. Based on application, the market is segmented into Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology and Microbiology. Based on material, the market is segmented into Polystyrene, Polypropylene and Glass. Based on end user, the market is segmented into Clinical Laboratories, Hospitals and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The single-use labware segment is growing rapidly because labs and clinical workflows continue to put an emphasis on controlling the contamination of specimens and performing procedures quickly and easily. Disposable labware decreases the risk of cross-contamination, eliminates the need for complicated sterilization cycles, creates a tighter assay reproducibility, and allows for more samples to be processed quickly than with reusable labware. Automation compatibility and ease of scaling the supply chain contribute to the increased use of disposable labware. As disposable labware manufacturers focus on standardizing quality and complying with regulations, they will continue to increase the preference for single-use labware in diagnostic assay workflows and for procurement choices.
As per IVD labware market forecast, the reusable labware segment is experiencing the most significant growth as a result of an increased focus on sustainability and improved sterilization methods. Reusable labware is made with durable materials and can be cleaned according to validated protocols, resulting in lower costs over the life of the product. The development of coatings that resist wear and abrasion and the establishment of vendor-certified reprocessing will further accelerate the adoption of reusable labware and will create new service-based business models.
Polypropylene has the largest market share because it has high chemical resistance and low binding of biomolecules that preserve sample integrity throughout many different types of assays. Its excellent thermal stability allows for the ability to sterilize samples efficiently and produce consistent parts with precise dimensions that lend themselves well to automated handling systems. Manufacturers often choose polypropylene due to its relatively low cost, flexibility to be used in a variety of formats, and ability to reduce the variability associated with conducting assays and assist with the overall management of inventory in their supply chain, further contributing to the competitiveness of the polypropylene market as a whole especially within the emerging diagnostic assay workflow and global purchasing strategies.
As per IVD labware market analysis, the Polystyrene market is rapidly growing because it has higher levels of optical clarity than polypropylene. Furthermore, there are innovative surface treatments and newly developed formulations that enhance assay performance and increase the demand for products produced with polystyrene. Examples of this would be working with surface chemistries and cell culture grade formulations that would expand its use in immunodiagnosis(style; cell culture, immunoassays), which creates the need for new consumables to support emerging assay formats.
To get detailed segments analysis, Request a Free Sample Report
The IVD labware market is led by North America, primarily due to an integrated ecosystem that includes advanced research institutions, specialized clinical labs, and a strong manufacturing base. The synergy of collaboration between academia and healthcare systems as well as the industry will help speed product development and adoption (and provide reliable avenues for regulatory approval) while substantial investments in automation, high-throughput diagnostics and quality management will yield more efficient and repeatable operations across all sectors. Additionally, the commitment to innovation will be supported by a well-established reimbursement mechanism and a large concentration of venture capital funding to facilitate commercialization of emerging technologies. A qualified workforce combined with proximity to some of the world's leading thought leaders in IVD, along with collaborative networks of clinical trials, will further enhance the adoption of advanced labware solutions in each diagnostic segment.
IVD Labware Market in United States is characterized by an advanced diagnostic industry, a high-density network of clinical research organizations and a close relationship between manufacturers and their end users. The concentration of innovative suppliers, the proliferation of specialty service ecosystems and the market demand for automated processes fuel continuous improvement of IVD products. This is manifested through a focus on quality, validation of testing protocols, and provision of technical support from the manufacturers of IVD products, as well as through procurement processes that favour those vendors who provide integrated solutions for their customers, the ability to provide excellent post-sale service and strong national distribution arrangements with third-party distributors.
IVD Labware Market in Canada is characterised by a cooperative public healthcare system, the need for standardized laboratory procedures and the availability of regional centres of excellence to support the adoption of cutting-edge labware. Procurement cycles place a high priority on delivering reliable supplier relationships, which are built on validated supplier performance. Although there is less domestic manufacturing activity, there are still ample import sources and strong connections with both Canadian and American supply chains that allow IVD labs access to a broad range of options for IVD products and technical support designed specifically for use within a clinical laboratory across Canada.
Europe rapid expansion in IVD labware stems from a confluence of strong scientific capability, supportive regulatory harmonization, and collaborative healthcare infrastructures. Investment in translational research fosters closer links between assay developers and labware manufacturers, accelerating local customization and validation. Centralized procurement frameworks and cross-border clinical networks promote wider uptake of standardized labware, while an emphasis on diagnostic accuracy and laboratory accreditation raises demand for high-quality consumables and automation. Diverse market dynamics across major economies encourage specialized suppliers to tailor offerings for clinical laboratories, research institutions, and private diagnostic providers, enhancing regional competitiveness and innovation. Clusters of medtech expertise, particularly around dominant industrial hubs, support scale-up and contract manufacturing. Growing emphasis on interoperability with laboratory information systems and adherence to international quality standards further incentivize laboratories to upgrade labware for efficiency and traceability. Public funding mechanisms and private partnerships help de-risk commercialization.
IVD Labware Market in Germany benefits from a strong industrial base in precision manufacturing, dense clinical research networks, and rigorous quality standards that shape supplier and laboratory behavior. Demand favors robust, validated labware compatible with automation and accredited workflows. Close collaboration between universities, diagnostic companies, and contract manufacturers supports localized innovation and customization. Procurement emphasizes long-term supplier relationships, service capacity, and conformity to regulatory and accreditation expectations across hospital laboratory settings.
IVD Labware Market in United Kingdom shows dynamic uptake driven by strong life science clusters, agile regulatory engagement, and active private sector investment supporting commercialization. Laboratories and diagnostic developers favor modular, automation-ready labware that facilitates flexible workflows. Emphasis on translational research and public-private collaboration speeds validation and market access. Procurement increasingly values interoperability, digital integration, and supplier responsiveness, creating fertile conditions for emerging suppliers and novel labware tailored to clinical needs.
IVD Labware Market in France is emerging through focused public research initiatives, specialized clinical laboratories, and growing engagement by domestic suppliers. Laboratories emphasize validated protocols, compatibility with established automation platforms, and alignment with accreditation requirements. Strategic partnerships between research hospitals and industry enable local testing and customization, while procurement balances quality expectations with demand for adaptable consumables. The market environment supports niche innovations and improvements that respond to laboratory workflow needs.
Asia Pacific is strengthening its role in the IVD labware market through strategic investment in local manufacturing capabilities, growing scientific expertise, and targeted policies that support diagnostic innovation. Regional players are improving material quality and production standards to meet international expectations while forging partnerships with multinational suppliers to access advanced technologies and distribution networks. Expansion of clinical research infrastructure and rising demand from varied care settings encourage suppliers to localize product configurations. Greater emphasis on regulatory clarity and laboratory accreditation elevates procurement requirements, prompting adoption of higher performance labware and enabling more competitive regional supply chains. In key markets, advanced automation and materials science expertise support development of precision consumables and durable labware suited for high-throughput and point-of-care applications. Strengthened technical training programs and increasing collaboration between industry and academic institutions contribute to a more capable workforce, while exporters leverage cost and scale advantages to compete in global supply networks.
IVD Labware Market in Japan leverages deep expertise in precision manufacturing, materials engineering, and automation integration to supply high-quality labware suited to advanced diagnostic workflows. Strong collaboration between industrial researchers and clinical laboratories supports rigorous validation and product refinement. Procurement often prioritizes durability, compatibility with automated platforms, and proven performance in accredited settings. Domestic suppliers focus on specialized, technically sophisticated consumables that meet strict quality expectations across hospital laboratory environments nationally.
IVD Labware Market in South Korea benefits from concentrated technology clusters, strong electronics sector, and proactive industry-academia collaboration that advances labware innovation. Local manufacturers emphasize rapid prototyping, integration with diagnostic platforms, and scalable production processes. Laboratories prioritize reliable, automation-compatible consumables and value technical support and supplier responsiveness. Export orientation and partnerships with global distributors enable South Korea suppliers to expand reach while continuing to refine products for domestic clinical needs nationally.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Diagnostic Testing Demand
Advances In Automation And Robotics
Supply Chain Constraints And Costs
Regulatory Complexity And Compliance Burden
Request Free Customization of this report to help us to meet your business objectives.
Competition in the global IVD labware market is driven by consolidation, product innovation, and sustainable supply shifts. Danaher's acquisition of Cytiva and Thermo Fisher's purchase of PPD exemplify consolidation to control consumables and services. Established firms invest in digitalization such as Eppendorf's connected pipette, while new entrants partner on plant based consumables to target sustainability sensitive diagnostic workflows.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global IVD labware market is being propelled primarily by escalating demand for reliable high-throughput diagnostic testing, which drives adoption of validated consumables and traceable workflows. A second key driver is advances in laboratory automation and molecular diagnostics that increase need for standardized, automation-compatible plates, tips and cartridges. Growth is tempered by supply chain constraints and rising input costs that can create shortages and procurement uncertainty for laboratories. North America remains the dominant region due to its integrated research, clinical and manufacturing ecosystem. Single-use labware is the leading segment as laboratories prioritize contamination control, fast turnaround and compatibility with automated platforms.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 3.6 Billion |
| Market size value in 2033 | USD 6.08 Billion |
| Growth Rate | 6.0% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the IVD Labware Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the IVD Labware Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the IVD Labware Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the IVD Labware Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Global Ivd Labware Market size was valued at USD 3.6 Billion in 2024 and is poised to grow from USD 3.82 Billion in 2025 to USD 6.08 Billion by 2033, growing at a CAGR of 6.0% during the forecast period (2026-2033).
Competition in the global IVD labware market is driven by consolidation, product innovation, and sustainable supply shifts. Danaher's acquisition of Cytiva and Thermo Fisher's purchase of PPD exemplify consolidation to control consumables and services. Established firms invest in digitalization such as Eppendorf's connected pipette, while new entrants partner on plant based consumables to target sustainability sensitive diagnostic workflows. 'Thermo Fisher Scientific Inc.', 'Danaher Corporation (Beckman Coulter, Cytiva)', 'Becton, Dickinson and Company', 'Corning Incorporated', 'Eppendorf AG', 'F. Hoffmann-La Roche Ltd.', 'Abbott Laboratories', 'Siemens Healthineers AG', 'Bio-Rad Laboratories Inc.', 'QIAGEN N.V.', 'Greiner Bio-One International GmbH', 'SARSTEDT AG & Co. KG', 'Hamilton Company', 'PerkinElmer Inc.', 'Agilent Technologies Inc.', 'DWK Life Sciences', 'Kartell S.p.A.', 'Tarsons Products Limited', 'Merck KGaA', 'Avantor Inc.'
Growing demand for diagnostic testing expands laboratory workloads and increases need for dependable, high-quality labware. As more tests are performed across clinical and decentralized settings, laboratories require consistent supplies of consumables, sample handling products, and storageware to maintain workflow efficiency and result reliability. This sustained demand encourages manufacturers to scale production, introduce product variants, and broaden distribution, thereby supporting market expansion through stronger procurement cycles, longer supplier relationships, and enhanced investment in capacity to meet evolving laboratory needs and accelerate innovation adoption.
Point Of Care Expansion: The shift toward decentralized testing is driving demand for labware designed for point of care and near patient settings. Manufacturers are prioritizing compact, robust, intuitive consumables that integrate with portable analyzers and field workflows. This trend encourages partnerships with clinical networks and developers of rapid diagnostic platforms and requires product adaptations for varying conditions. Emphasis on ease of use, waste management, cold chain independence and consistent performance in non laboratory environments is reshaping research and development and commercial strategies.
Why does North America Dominate the Global IVD Labware Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients